Use of Brevibacillus choshinensis for the production of biologically active brain-derived neurotrophic factor (BDNF)

Phillip A. Angart, Rebecca J. Carlson, Sarah Thorwall, S. Patrick Walton

    Research output: Contribution to journalArticle

    Abstract

    Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family critical for neuronal cell survival and differentiation, with therapeutic potential for the treatment of neurological disorders and spinal cord injuries. The production of recombinant, bioactive BDNF is not practical in most traditional microbial expression systems because of the inability of the host to correctly form the characteristic cystine-knot fold of BDNF. Here, we investigated Brevibacillus choshinensis as a suitable expression host for bioactive BDNF expression, evaluating the effects of medium type (2SY and TM), temperature (25 and 30 °C), and culture time (48–120 h). Maximal BDNF bioactivity (per unit mass) was observed in cultures grown in 2SY medium at extended times (96 h at 30 °C or >72 h at 25 °C), with resulting bioactivity comparable to that of a commercially available BDNF. For cultures grown in 2SY medium at 25 °C for 72 h, the condition that led to the greatest quantity of biologically active protein in the shortest culture time, we recovered 264 μg/L of BDNF. As with other microbial expression systems, BDNF aggregates did form in all culture conditions, indicating that while we were able to recover biologically active BDNF, further optimization of the expression system could yield still greater quantities of bioactive protein. This study provides confirmation that B. choshinensis is capable of producing biologically active BDNF and that further optimization of culture conditions could prove valuable in increasing BDNF yields.

    Original languageEnglish (US)
    Pages (from-to)1-8
    Number of pages8
    JournalApplied Microbiology and Biotechnology
    DOIs
    StateAccepted/In press - May 2 2017

    Profile

    Brevibacillus
    Brain-Derived Neurotrophic Factor
    Proteins
    Cystine
    Nervous System Diseases
    Spinal Cord Injuries
    Cell Differentiation
    Cell Survival
    Temperature

    Keywords

    • BDNF
    • Bioactive
    • Brain-derived neurotrophic factor
    • Brevibacillus choshinensis
    • Cystine-knot protein
    • Neurotrophin
    • Recombinant

    ASJC Scopus subject areas

    • Biotechnology
    • Applied Microbiology and Biotechnology

    Cite this

    Use of Brevibacillus choshinensis for the production of biologically active brain-derived neurotrophic factor (BDNF). / Angart, Phillip A.; Carlson, Rebecca J.; Thorwall, Sarah; Patrick Walton, S.

    In: Applied Microbiology and Biotechnology, 02.05.2017, p. 1-8.

    Research output: Contribution to journalArticle

    Angart, Phillip A.; Carlson, Rebecca J.; Thorwall, Sarah; Patrick Walton, S. / Use of Brevibacillus choshinensis for the production of biologically active brain-derived neurotrophic factor (BDNF).

    In: Applied Microbiology and Biotechnology, 02.05.2017, p. 1-8.

    Research output: Contribution to journalArticle

    @article{c1b1a0aba6664120999772e3dfb78116,
    title = "Use of Brevibacillus choshinensis for the production of biologically active brain-derived neurotrophic factor (BDNF)",
    abstract = "Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family critical for neuronal cell survival and differentiation, with therapeutic potential for the treatment of neurological disorders and spinal cord injuries. The production of recombinant, bioactive BDNF is not practical in most traditional microbial expression systems because of the inability of the host to correctly form the characteristic cystine-knot fold of BDNF. Here, we investigated Brevibacillus choshinensis as a suitable expression host for bioactive BDNF expression, evaluating the effects of medium type (2SY and TM), temperature (25 and 30 °C), and culture time (48–120 h). Maximal BDNF bioactivity (per unit mass) was observed in cultures grown in 2SY medium at extended times (96 h at 30 °C or >72 h at 25 °C), with resulting bioactivity comparable to that of a commercially available BDNF. For cultures grown in 2SY medium at 25 °C for 72 h, the condition that led to the greatest quantity of biologically active protein in the shortest culture time, we recovered 264 μg/L of BDNF. As with other microbial expression systems, BDNF aggregates did form in all culture conditions, indicating that while we were able to recover biologically active BDNF, further optimization of the expression system could yield still greater quantities of bioactive protein. This study provides confirmation that B. choshinensis is capable of producing biologically active BDNF and that further optimization of culture conditions could prove valuable in increasing BDNF yields.",
    keywords = "BDNF, Bioactive, Brain-derived neurotrophic factor, Brevibacillus choshinensis, Cystine-knot protein, Neurotrophin, Recombinant",
    author = "Angart, {Phillip A.} and Carlson, {Rebecca J.} and Sarah Thorwall and {Patrick Walton}, S.",
    year = "2017",
    month = "5",
    doi = "10.1007/s00253-017-8273-x",
    pages = "1--8",
    journal = "Applied Microbiology and Biotechnology",
    issn = "0175-7598",
    publisher = "Springer Verlag",

    }

    TY - JOUR

    T1 - Use of Brevibacillus choshinensis for the production of biologically active brain-derived neurotrophic factor (BDNF)

    AU - Angart,Phillip A.

    AU - Carlson,Rebecca J.

    AU - Thorwall,Sarah

    AU - Patrick Walton,S.

    PY - 2017/5/2

    Y1 - 2017/5/2

    N2 - Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family critical for neuronal cell survival and differentiation, with therapeutic potential for the treatment of neurological disorders and spinal cord injuries. The production of recombinant, bioactive BDNF is not practical in most traditional microbial expression systems because of the inability of the host to correctly form the characteristic cystine-knot fold of BDNF. Here, we investigated Brevibacillus choshinensis as a suitable expression host for bioactive BDNF expression, evaluating the effects of medium type (2SY and TM), temperature (25 and 30 °C), and culture time (48–120 h). Maximal BDNF bioactivity (per unit mass) was observed in cultures grown in 2SY medium at extended times (96 h at 30 °C or >72 h at 25 °C), with resulting bioactivity comparable to that of a commercially available BDNF. For cultures grown in 2SY medium at 25 °C for 72 h, the condition that led to the greatest quantity of biologically active protein in the shortest culture time, we recovered 264 μg/L of BDNF. As with other microbial expression systems, BDNF aggregates did form in all culture conditions, indicating that while we were able to recover biologically active BDNF, further optimization of the expression system could yield still greater quantities of bioactive protein. This study provides confirmation that B. choshinensis is capable of producing biologically active BDNF and that further optimization of culture conditions could prove valuable in increasing BDNF yields.

    AB - Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family critical for neuronal cell survival and differentiation, with therapeutic potential for the treatment of neurological disorders and spinal cord injuries. The production of recombinant, bioactive BDNF is not practical in most traditional microbial expression systems because of the inability of the host to correctly form the characteristic cystine-knot fold of BDNF. Here, we investigated Brevibacillus choshinensis as a suitable expression host for bioactive BDNF expression, evaluating the effects of medium type (2SY and TM), temperature (25 and 30 °C), and culture time (48–120 h). Maximal BDNF bioactivity (per unit mass) was observed in cultures grown in 2SY medium at extended times (96 h at 30 °C or >72 h at 25 °C), with resulting bioactivity comparable to that of a commercially available BDNF. For cultures grown in 2SY medium at 25 °C for 72 h, the condition that led to the greatest quantity of biologically active protein in the shortest culture time, we recovered 264 μg/L of BDNF. As with other microbial expression systems, BDNF aggregates did form in all culture conditions, indicating that while we were able to recover biologically active BDNF, further optimization of the expression system could yield still greater quantities of bioactive protein. This study provides confirmation that B. choshinensis is capable of producing biologically active BDNF and that further optimization of culture conditions could prove valuable in increasing BDNF yields.

    KW - BDNF

    KW - Bioactive

    KW - Brain-derived neurotrophic factor

    KW - Brevibacillus choshinensis

    KW - Cystine-knot protein

    KW - Neurotrophin

    KW - Recombinant

    UR - http://www.scopus.com/inward/record.url?scp=85018372362&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85018372362&partnerID=8YFLogxK

    U2 - 10.1007/s00253-017-8273-x

    DO - 10.1007/s00253-017-8273-x

    M3 - Article

    SP - 1

    EP - 8

    JO - Applied Microbiology and Biotechnology

    T2 - Applied Microbiology and Biotechnology

    JF - Applied Microbiology and Biotechnology

    SN - 0175-7598

    ER -